Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-25-016734

CHIEF OPERATING OFFICER sold 6,667 shares at an average $20.34 ($135,574)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-09 Sale : show line 1 in the form 10b5-1 −6,607 $20.33 $134,304 303,369 I
2025-06-09 Sale : show line 2 in the form 10b5-1 −60 $21.16 $1,270 303,309 I
Open-market sales · 6,667 sh · avg $20.34 · $135,574
Loading xslF345X05/form4-06112025_100610.xml…